Sore Throat

Background

Sore throat — clinically pharyngitis — is one of the most common reasons people seek symptom relief, and one of the most common reasons antibiotics are prescribed unnecessarily. The large majority of sore throats are viral, caused by the same family of respiratory viruses responsible for colds and influenza. A smaller proportion are bacterial, with group A Streptococcus (the cause of "strep throat") being the bacterial pathogen most often cited. Distinguishing the two from symptoms alone is unreliable, which is why clinicians use scoring systems and, where appropriate, swab tests.

Most viral sore throats are self-limiting and resolve within three to seven days without specific treatment. The discomfort is largely produced by inflammation of pharyngeal tissue and the body's immune response, rather than by tissue damage from the virus itself. That is why symptom relief — anything that calms inflammation, soothes the mucosa, or reduces cough that further irritates the throat — is the main thing most people are looking for.

Bacterial pharyngitis behaves differently. It can be associated with higher fevers, more pronounced swelling, and, in the case of untreated streptococcal infection, occasional complications that warrant antibiotic treatment. A clinician — not a search engine, and not a honey jar — is the right person to make that call when the picture is severe or unusual.

How Manuka may help

Three plausible mechanisms are usually proposed for honey in sore throat, and it is worth being clear about how well each is supported.

The first is antibacterial action. Manuka honey carries non-peroxide antibacterial activity attributed mainly to methylglyoxal (MGO), a compound that accumulates during ripening from a precursor in fresh Leptospermum scoparium nectar. In laboratory conditions, Manuka honey at defined MGO concentrations inhibits a broad range of bacteria. That mechanism is well characterised in vitro; whether it translates into a meaningful effect against the viral causes of most sore throats — where bacteria are not the primary driver — is a different question, and not one in-vitro data can answer on its own.

The second is anti-inflammatory action. Honey has been observed to influence inflammatory signalling in laboratory models, which offers a plausible rationale for the soothing effect people describe. This sits closer to mechanism than to clinical evidence: it is consistent with what people report, but the direct chain from a jar to a measured anti-inflammatory effect in a human throat is not established at the level of a clinical trial.

The third is the demulcent or coating effect. Honey is a viscous, sugar-rich liquid; when allowed to coat pharyngeal tissue rather than washed down with water, it forms a temporary protective layer over irritated mucosa. This is a physical effect rather than a pharmacological one, and it is the mechanism most easily explained without invoking unique properties of Manuka. It is plausibly the dominant reason a teaspoon of any honey can take the edge off throat soreness.

The honest framing is that mechanism and clinical efficacy are different things. Manuka honey has more characterised antibacterial activity than ordinary honey; whether that is what is doing the work in symptom relief, versus the demulcent and anti-inflammatory effects shared with honey generally, is not settled.

What the evidence shows

The strongest review-level evidence for honey in sore throat sits in the broader literature on upper respiratory tract infection (URTI) symptoms, particularly cough — which is closely entangled with throat irritation. A 2020 systematic review and meta-analysis (Abuelgasim, Albury, Lee — BMJ Evidence-Based Medicine) pooled randomised and non-randomised studies and found that honey was associated with greater improvement than usual care in cough frequency and severity in URTIs, with effect sizes that were modest but consistent. The review's conclusion was framed in terms of symptom improvement and a reduced reliance on antibiotics — not in terms of curing infection.

Two qualifications matter for how that evidence applies here. First, most of the trials included in the review studied honey generally, not Manuka honey specifically. The systematic-review evidence supports "honey for cough and sore throat symptoms" more than it supports any particular varietal. Second, the review measured symptom outcomes — frequency, severity, time to resolution — rather than microbiological cure. The right reading is that honey appears to help people feel better faster; it is not a stand-in for antibiotics where antibiotics are indicated.

For Manuka honey specifically, the evidence narrows. Laboratory work consistently shows in-vitro activity against common throat pathogens at MGO concentrations corresponding to roughly UMF 15+ and above, and a randomised controlled trial in chronic wound care demonstrated sustained activity against bacteria including MRSA in that setting. Translating wound-care evidence to throat use is an extrapolation, not a direct claim — and it is one we are deliberately careful with.

What the evidence does not support is language like "treats", "cures", or "replaces antibiotics for". The systematic-review base sits at symptom reduction, the in-vitro and wound-care literature sits at characterised antibacterial activity in those specific contexts, and statements stronger than that should be read as marketing rather than evidence.

Practical use

Traditional and observational use is straightforward: a teaspoon of honey (around 5–7g) taken neat, allowed to dissolve slowly in the mouth so it coats the throat. The point is contact time with pharyngeal tissue, which is why washing it down with water immediately defeats the purpose. In trials of honey for cough and sore throat, dosing patterns of a few teaspoons across the day, including one before bed, are common.

For grade selection, traditional and laboratory references for throat use cluster around UMF 15+ (approximately MGO 514+), with UMF 20+ sometimes chosen by people who want the higher non-peroxide activity reported in laboratory work. Lower grades such as UMF 5+ and UMF 10+ carry less measured antibacterial activity per gram and are more often used for everyday eating than for targeted symptom support. There is no clinical trial that defines an "optimal" grade for sore throat, so treat this as informed preference rather than a prescription. The UMF and MGO grading primer covers what each tier actually measures.

For practical timing, the how-to-use-manuka primer summarises the common patterns — a morning spoonful, a teaspoon before bed, repeated through the day during an active sore throat. None of this is prescriptive: it is what people typically do, drawn from the trial protocols and traditional patterns that exist.

If symptoms are getting worse rather than better after a few days, or if they appear with a high fever, difficulty swallowing, difficulty breathing, a rash, or a stiff neck, stop relying on home remedies and see a clinician. Honey is reasonable symptom support for a typical viral sore throat; it is not a substitute for medical assessment when something more is going on.